These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1079 related articles for article (PubMed ID: 25164003)

  • 1. The global burden of liver disease: the major impact of China.
    Wang FS; Fan JG; Zhang Z; Gao B; Wang HY
    Hepatology; 2014 Dec; 60(6):2099-108. PubMed ID: 25164003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global liver disease burdens and research trends: Analysis from a Chinese perspective.
    Xiao J; Wang F; Wong NK; He J; Zhang R; Sun R; Xu Y; Liu Y; Li W; Koike K; He W; You H; Miao Y; Liu X; Meng M; Gao B; Wang H; Li C
    J Hepatol; 2019 Jul; 71(1):212-221. PubMed ID: 30871980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
    Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
    Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatology after Hepatitis C.
    Fitz JG
    Dig Dis; 2016; 34(5):603-6. PubMed ID: 27332966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of four common non-infectious liver diseases for the hospitalized patients in Beijing 302 hospital from 2002 to 2013.
    Chang B; Li B; Huang A; Sun Y; Teng G; Wang X; Liangpunsakul S; Li J; Zou Z
    Alcohol; 2016 Aug; 54():61-5. PubMed ID: 27519542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of liver diseases in the world.
    Asrani SK; Devarbhavi H; Eaton J; Kamath PS
    J Hepatol; 2019 Jan; 70(1):151-171. PubMed ID: 30266282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the transmission dynamics and control of hepatitis B virus in China.
    Zou L; Zhang W; Ruan S
    J Theor Biol; 2010 Jan; 262(2):330-8. PubMed ID: 19822154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saudi association for the study of liver diseases and transplantation position statement on the hepatology workforce in Saudi Arabia.
    Al-Judaibi B; Dokus MK; Al-Hamoudi W; Broering D; Mawardi M; AlMasri N; Aljawad M; Altraif IH; Abaalkhail F; Alqahtani SA
    Saudi J Gastroenterol; 2022; 28(2):101-107. PubMed ID: 35295066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of viral hepatitis in Africa.
    Bojuwoye BJ
    West Afr J Med; 1997; 16(4):198-203. PubMed ID: 9473953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver disease in the HIV-infected individual.
    Price JC; Thio CL
    Clin Gastroenterol Hepatol; 2010 Dec; 8(12):1002-12. PubMed ID: 20851211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Challenges in liver diseases and transplantation].
    Ben Ari Z
    Harefuah; 2012 Dec; 151(12):660-1, 722. PubMed ID: 23330253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trend analysis on the disease burden related to cirrhosis and other chronic liver diseases caused by hepatitis B, in China, from 1990 to 2016].
    Zhang L; Fan ZF; Liu DW; Zhou MG; Wang ZQ; Li M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Feb; 41(2):173-177. PubMed ID: 32164125
    [No Abstract]   [Full Text] [Related]  

  • 14. Calling a stage-based treatment model for chronic liver diseases in China mainland.
    Liu X; Xu J
    Ann Hepatol; 2020; 19(6):585-589. PubMed ID: 31711913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disease burden of liver cancer in China: an updated and integrated analysis on multi-data source evidence].
    Cao MD; Wang H; Shi JF; Bai FZ; Cao MM; Wang YT; Yan XX; Wang L; Huang Z; Ren JS; Zhao JJ; Dai M; Qu CF; Chen WQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Nov; 41(11):1848-1858. PubMed ID: 33297650
    [No Abstract]   [Full Text] [Related]  

  • 16. [Epidemiological characteristics of familiar adult inherited metabolic liver disease].
    Liang C; Bai L; Duan ZP; Zheng SJ
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1224-1228. PubMed ID: 38238959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China.
    Lu J; Xu A; Wang J; Zhang L; Song L; Li R; Zhang S; Zhuang G; Lu M
    BMC Health Serv Res; 2013 Jan; 13():37. PubMed ID: 23368750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver damage in patients living with HIV on antiretroviral treatment with normal baseline liver function and without HBV/HCV infection: an 11-year retrospective cohort study in Guangxi, China.
    Qin F; Jiang J; Qin C; Huang Y; Liang B; Xu Y; Huang J; Xu Z; Ning C; Liao Y; Zang N; Lai J; Wei W; Yu J; Ye L; Qin X; Liang H
    BMJ Open; 2019 Apr; 9(4):e023140. PubMed ID: 30944128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 May; 56(18):441-5. PubMed ID: 17495790
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 54.